We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

96 hedge funds and large institutions have $578M invested in RAPT Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,631% more call options, than puts

Call options by funds: $9.89M | Put options by funds: $209K

3% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 36

0.26% more ownership

Funds ownership: 12.39% → 12.65% (+0.26%)

2% less funds holding

Funds holding: 98 → 96 (-2)

9% less capital invested

Capital invested by funds: $637M → $578M (-$59M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
96
Holders Change
-2
Holders Change %
-2.04%
% of All Funds
1.52%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
5
Increased
37
Reduced
36
Closed
7
Calls
$9.89M
Puts
$209K
Net Calls
+$9.68M
Net Calls Change
-$1.05M

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$10.1M
2
Millennium Management
Millennium Management
New York
+$7.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.3M
4
UBS AM
UBS AM
Illinois
+$5.65M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.65M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$7.51M
2
State Street
State Street
Massachusetts
-$6.03M
3
Deutsche Bank
Deutsche Bank
Germany
-$5.57M
4
KCM
Kingdon Capital Management
New York
-$3.96M
5
Morgan Stanley
Morgan Stanley
New York
-$2.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
$4.6M +$5.65M +34,594 New
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$3.79M +$4.65M +28,488 New
Charles Schwab
28
Charles Schwab
California
$3.69M +$489K +2,993 +12%
Goldman Sachs
29
Goldman Sachs
New York
$2.96M -$198K -1,214 -5%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$2.55M +$1.26M +7,729 +67%
SSA
31
Schonfeld Strategic Advisors
New York
$2.24M +$1.18M +7,256 +75%
Citadel Advisors
32
Citadel Advisors
Florida
$1.75M -$914K -5,598 -30%
VOYA Investment Management
33
VOYA Investment Management
Georgia
$1.67M – – –
Rafferty Asset Management
34
Rafferty Asset Management
New York
$1.63M -$595K -3,643 -23%
N
35
Nuveen
North Carolina
$1.62M +$241K +1,478 +14%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.57M +$326 +2 +0%
UOC
37
UBS O'Connor
Illinois
$1.56M -$61.2K -375 -3%
Bank of America
38
Bank of America
North Carolina
$1.54M +$392K +2,401 +26%
FAM
39
Fred Alger Management
New York
$1.43M -$1.48M -9,083 -46%
TOCUITCONY
40
Trustees of Columbia University in the City of New York
New York
$1.22M – – –
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.04M +$816 +5 +0.1%
AG
42
Algert Global
California
$1.03M -$274K -1,681 -18%
Two Sigma Advisers
43
Two Sigma Advisers
New York
$982K -$1.01M -6,200 -46%
Barclays
44
Barclays
United Kingdom
$892K -$220K -1,349 -17%
WP
45
Woodline Partners
California
$831K – – –
Swiss National Bank
46
Swiss National Bank
Switzerland
$816K +$87.8K +538 +10%
JFG
47
Jefferies Financial Group
New York
$810K – – –
JRP
48
Jasper Ridge Partners
California
$759K – – –
Jane Street
49
Jane Street
New York
$708K +$484K +2,968 +126%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$707K -$21.9K -134 -2%
1
2
3 4 5

RAPT Hedge Fund Activity: Q3 2023 in Review

96 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q3 2023, worth a combined $578M — down 9.3% from $637M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of RAPT and 5 opened new positions — a net loss of 2 holders — while 36 trimmed existing stakes and 37 added.

The largest buyer was Deep Track Capital, adding an estimated $10.1M. The largest seller was Perceptive Advisors, cutting an estimated $7.51M.

  • 96 institutional investors held RAPT Therapeutics (RAPT) as of Q3 2023, down from 98 in Q2 2023.
  • Funds reported $578M of RAPT Therapeutics stock for Q3 2023, down 9.3% quarter-over-quarter.
  • 5 funds opened new RAPT Therapeutics positions in Q3 2023 and 7 closed out, a net change of -2 holders.
  • The largest RAPT Therapeutics buyer in Q3 2023 was Deep Track Capital, an estimated $10.1M added.
  • The largest RAPT Therapeutics seller in Q3 2023 was Perceptive Advisors, an estimated $7.51M sold.

Based on aggregated 13F filings for Q3 2023.